secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMPACT BIOMEDICAL INC. (IBO)
CIK:        0001834105
Form:       8-K
Filed at:   2025-03-13T23:59:59+00:00
Accession:  0001493152-25-010190
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Impact Biomedical appoints Chan Heng Fai Ambrose to board of directors
----------------------------------------------------------------------

- Appointed March 11, 2025, effective same date; over 45 years financial/equity investment experience.
- Current director/chair roles include Alset International, DSS Inc., Hapi Metaverse, LiquidValue Development, Alset Inc., Sharing Services Global, HWH International, Value Exchange International.
- No arrangement or understanding with any other person for appointment; no family relationships or related-party transactions per Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834105/000149315225010190/0001493152-25-010190-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834105/000149315225010190/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-010190

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer